Not Enrolling, but Ongoing

Study of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women
Sponsor: University of California, Los Angeles, Merck, Case Western Reserve
Contact: Rosemarie Clarke
(416) 340-4800 ext. 6723 or
Adriana D’Aquila
(416) 340-4800 ext. 8170

Completed Studies with Results

Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS)

A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve Women
(ARIA, ING117172)

Phase II Study of Raltegravir as Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Based Antiretroviral Therapy in Women With Fat Accumulation (CARE 001)